Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sorrento Therapeutics (DE:8STN)
FRANKFURT:8STN
Sorrento Therapeutics (8STN) Financial Statements
0 Followers
Sorrento Therapeutics Financial Overview
| Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 10.60M | $ 15.59M | $ 17.40M | $ 11.46M | $ 18.39M |
| Gross Profit | $ -8.99M | $ -5.42M | $ 9.13M | $ 5.76M | $ 12.63M |
| EBIT | $ -141.66M | $ -210.98M | $ -90.91M | $ -218.28M | $ -35.70M |
| EBITDA | $ -120.30M | $ -209.85M | $ -87.55M | $ -215.05M | $ -32.40M |
| Net Income Common Stockholders | $ -139.62M | $ -223.69M | $ -89.58M | $ -218.76M | $ -40.81M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 50.32M | $ 49.98M | $ 117.86M | $ 133.60M | $ 270.66M |
| Total Assets | $ 460.06M | $ 472.84M | $ 615.61M | $ 632.13M | $ 855.64M |
| Total Debt | $ 169.55M | $ 134.50M | $ 168.21M | $ 204.61M | $ 248.88M |
| Net Debt | $ 119.23M | $ 84.53M | $ 50.35M | $ 71.00M | $ -21.77M |
| Total Liabilities | $ 587.48M | $ 494.51M | $ 485.41M | $ 496.37M | $ 629.44M |
| Stockholders Equity | $ -125.50M | $ -18.61M | $ 131.85M | $ 132.02M | $ 226.54M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -49.55M | $ -72.86M | $ -65.01M | $ -83.69M | $ -85.95M |
| Operating Cash Flow | $ -49.46M | $ -68.34M | $ -61.17M | $ -80.99M | $ -83.36M |
| Investing Cash Flow | $ 1.68M | $ -5.03M | $ -8.09M | $ -1.73M | $ -13.66M |
| Financing Cash Flow | $ 61.20M | $ 25.08M | $ 71.50M | $ 41.77M | $ 173.37M |
Sorrento Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.